a public good project by the
Synthesis
Company
of California

© 2026

Pamela M. Pollock | doi.page

0 works0 citations0 h-index

Pamela M. Pollock

Translational Research Institute(AU)Queensland University of Technology(AU)

Publications by Year

Research Areas

Fibroblast Growth Factor Research, Endometrial and Cervical Cancer Treatments, Kruppel-like factors research, Cancer Genomics and Diagnostics, Melanoma and MAPK Pathways

Most-Cited Works

→ Molecular Classification of the PORTEC-3 Trial for High-Risk Endometrial Cancer: Impact on Prognosis and Benefit From Adjuvant Therapy(2020)790 cited
→ Refining prognosis and identifying targetable pathways for high-risk endometrial cancer; a TransPORTEC initiative(2015)481 cited
→ Proteasome Inhibitors Trigger NOXA-Mediated Apoptosis in Melanoma and Myeloma Cells(2005)336 cited
→ Frequent activating FGFR2 mutations in endometrial carcinomas parallel germline mutations associated with craniosynostosis and skeletal dysplasia syndromes(2007)303 cited
→ Melanoma mouse model implicates metabotropic glutamate signaling in melanocytic neoplasia(2003)293 cited
→ The CDKN2A (p16) Gene and Human Cancer(1997)274 cited

→ Brivanib Alaninate, a Dual Inhibitor of Vascular Endothelial Growth Factor Receptor and Fibroblast Growth Factor Receptor Tyrosine Kinases, Induces Growth Inhibition in Mouse Models of Human Hepatocellular Carcinoma(2008)

221 cited

→ FGFR2 Point Mutations in 466 Endometrioid Endometrial Tumors: Relationship with MSI, KRAS, PIK3CA, CTNNB1 Mutations and Clinicopathological Features(2012)186 cited

→ Microarray expression profiling in melanoma reveals a BRAF mutation signature(2004)183 cited

→ Compilation of somatic mutations of theCDKN2 gene in human cancers: Non-random distribution of base substitutions(1996)173 cited